A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.

R T Costello; S Sivori; F Mallet; D Sainty; C Arnoulet; D Reviron; J-A Gastaut; A Moretta; D Olive

doi:10.1038/sj.leu.2402488

A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.

Identifier:nobleid.org/w1/20260515/307CF72F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/307CF72F.svg?ark=w1%2F20260515%2F307CF72F)](https://nobleid.org/work/w1/20260515/307CF72F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.

Identifier:nobleid.org/w1/20260515/307CF72F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/307CF72F.svg?ark=w1%2F20260515%2F307CF72F)](https://nobleid.org/work/w1/20260515/307CF72F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work